NICE urges drug-eluting stent use in severe coronary artery disease

Drug-eluting stents should be used in patients with severe coronary artery disease, according to a draft NICE guideline.

coronary stent
coronary stent

The move is hoped to prevent repeated replacement of bare metal stents. Patients will be eligible if they have a coronary artery smaller than 3mm in diameter or the section of artery to be stented is longer than 15mm.

However, drug-eluting stents should only be used if it costs no more than £300 above the price of a bare metal stent. The guideline is open to appeal until 15 February.

rachel.liddle@haymarket.com

NICE quideline

Comment below and tell us what you think

 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus